STOCK TITAN

Albireo Pharma Stock Price, News & Analysis

ALBO NASDAQ

Company Description

Albireo Pharma (NASDAQ: ALBO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

ALBO stock has gained 64.6% over the past year.

This page provides a comprehensive overview of ALBO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+64.62%
Performance 1 year

Albireo Pharma (ALBO) stock. Over the past 12 months, the stock has gained 64.6%.

Latest News

Albireo Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include fda approval, acquisition, management, conferences, earnings. View all ALBO news →

SEC Filings

No SEC filings available for ALBO.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ALBO Company Profile & Sector Positioning

Albireo Pharma (ALBO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.